ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "meta-analysis"

  • Abstract Number: 1465 • ACR Convergence 2023

    Blood-dominant Disease in Older-onset Lupus: A Systematic Review and Meta-analysis

    Sarah Abi Doumeth1, Marina Nighat Magrey2 and Omer Pamuk3, 1Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, 2Case Western Reserve University, University Hospitals, Cleveland, OH, 3University Hospitals Cleveland Medical Center, Cleveland, OH

    Background/Purpose: Previous studies have shown that the clinical manifestations of systemic lupus erythematosus (SLE) differ based on age of onset. Late onset SLE has been…
  • Abstract Number: 1467 • ACR Convergence 2023

    Antiphospholipid Antibodies and the Risk of Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

    Mariana Gonzalez-Trevino1, Jeffrey Yang2, Larry J. Prokop3, Gabriel Figueroa-Parra1 and Ali Duarte-Garcia4, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Internal Medicine, Mayo Clinic, Rochester, MN, 3Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, MN

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is one of the most devastating complications of SLE. The exact pathogenesis leading to DAH in SLE is not well…
  • Abstract Number: 2123 • ACR Convergence 2022

    Hierarchical Ranking of Biologic Disease-Modifying Antirheumatic Drugs and Targeted Systemic Therapies for Psoriatic Arthritis: A Network Meta-analysis

    Jesus Diaz1, Guillermo Quiceno2 and Adela Castro3, 1Hamilton Medical Center, Chattanooga, TN, 2UT Southwestern Medical Center, Dallas, TX, 3Hamilton Physician Group-Specialty Care, Dalton, GA

    Background/Purpose: There are an increasing number of biological and targeted DMARDs in PsA. However, challenges around treatment selection remain, given the few head-to-head studies directly…
  • Abstract Number: 0141 • ACR Convergence 2022

    Is Rituximab Associated with Worse Outcomes in COVID-19 Patients? A Meta-analysis

    Yasmin Gerais1, Chenyu Sun1, Bethany King2, Scott Lowe3, Biniyam Mohammed1, Rachel Bentley3, Yaru Li4, Binyu Wei5 and Chuanhui Xu6, 1Ascension Saint Joseph hospital, Chicago, IL, 2MercyOne Des Moines Medical center, Des Moines, IA, 3College of Osteopathic Medicine, Kansas City University, Kansas, MO, 4Swedish Hospital, Chicago, IL, 5Harvard Medical School, Boston, MA, 6Tan Tock Seng Hospital, Singapore, Singapore

    Background/Purpose: Rituximab targets the CD20 antigen to deplete B cells and is indicated for a number of autoimmune diseases and other conditions. Accumulating data suggest…
  • Abstract Number: 2169 • ACR Convergence 2022

    Cardiac Rhythm and Conduction Abnormalities in Systemic Sclerosis-meta-analysis

    Drashti Antala1, Angkawipa Trongtorsak1, Qingqing Meng1, Akshaya Ramachandran1, Aanshi Patel2, Pabitra Adhikari1, Prasun Pudasainee1 and Krutarth Pandya3, 1Ascension Saint Francis hospital, Evanston, IL, 2B.J. Medical College, Ahmedabad, Ahmedabad, India, 3Trumbull Regional Medical Centre, Warren, OH

    Background/Purpose: Systemic sclerosis( SSc) can primarily cause repeated focal ischaemic insults in the myocardium and result in irreversible myocardial fibrosis. Myocardial involvement, when becomes clinically…
  • Abstract Number: 0328 • ACR Convergence 2022

    Predicting Progression from Undifferentiated to Definitive Connective Tissue Diseases: A Systematic Review and Meta-analysis

    Sarah Dyball1, Mia Rodziewicz1, Claudia Mendoza Pinto2, Ian N. Bruce3 and Ben Parker4, 1The University of Manchester, Manchester, United Kingdom, 2Systemic Autoimmune Diseases Research Unit, High-Specialty Medical Unit-CIBIOR, Mexican Social Security Institute, Puebla, Mexico, 3Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom, 4Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

    Background/Purpose: Undifferentiated connective tissue disease (UCTD) encapsulates a broad range of conditions including incomplete forms of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), some…
  • Abstract Number: 0426 • ACR Convergence 2022

    The Relative Efficacy of Biologic and Targeted Synthetic DMARDs in Ankylosing Spondylitis: A Network Meta-Analysis

    Jesus Diaz1, Guillermo Quiceno2, Cathy Lee Ching3 and Adela Castro4, 1Hamilton Medical Center, Chattanooga, TN, 2UT Southwestern Medical Center, Dallas, TX, 3University of Mississippi Medical Center, Jackson, MS, 4Hamilton Physician Group-Specialty Care, Dalton, GA

    Background/Purpose: There is an unmet medical need for the treatment of patients with active ankylosing spondylitis (AS) who have an inadequate response to NSAIDs. Prior…
  • Abstract Number: 0484 • ACR Convergence 2022

    Epidemiology and Predictors of Relapse in Giant Cell Arteritis: A Systematic Review and Meta-analysis

    Lien Moreel1, Albrecht Betrains1, Geert Molenberghs2, Steven Vanderschueren1 and Daniel Blockmans1, 1University Hospitals Leuven, KU Leuven, Leuven, Belgium, 2KU Leuven, Leuven, Belgium

    Background/Purpose: The aim of this study was to estimate the timing of relapse, the prevalence of multiple relapses and the predictors of relapse in patients…
  • Abstract Number: 0739 • ACR Convergence 2022

    Effect of Tailored Self-Management Interventions on Health Outcomes in Individuals with Chronic Musculoskeletal Conditions

    Ellen Wang1, Isabel Rodrigues2 and Linda Li3, 1University of British Columbia, Arthritis Research Canada, Vancouver, BC, Canada, 2McMaster University, GERAS Centre for Aging Research, Hamilton, ON, Canada, 3University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Self-management, has been recognized as an essential component of successful chronic musculoskeletal (MSK) management; yet existing reviews of self-management interventions have found only modest…
  • Abstract Number: 0803 • ACR Convergence 2022

    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

    Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

    Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring…
  • Abstract Number: 0914 • ACR Convergence 2022

    The Impact of Autoantibodies (RF and ACPA) on the Efficacy of Biological Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Meta-analysis of Randomized Controlled Trials

    Kaoru Takase-Minegishi1, Stephan Böhringer2, Jackie Nam3, Yuko Kaneko4, Frank Behrens5, Saedis Saevarsdottir6, Jacqueline Detert7, Marjatta Leirisalo-Repo8, Désirée van der Heijde9, Robert Landewé10, Sofia Ramiro11 and Diane van der Woude12, 1Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan, 2Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Leiden, Netherlands, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, United Kingdom, 4Keio University School of Medicine, Tokyo, Japan, 5CIRI/Rheumatology and Fraunhofer Institute, Translational Medicine and Pharmacology ITMP, Goethe University, Frankfurt, Germany, 6Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden and Faculty of Medicine, University of Iceland, Stockholm, Sweden, 7Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 8Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 9Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 10Amsterdam University Medical Center, Meerssen, Netherlands, 11Leiden University Medical Center, Leiden, Netherlands, 12Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The impact of autoantibodies on the efficacy of bDMARDs in patients with rheumatoid arthritis (RA) is not yet clear. Despite the fact that this…
  • Abstract Number: 1240 • ACR Convergence 2022

    A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy for the Diagnosis of Cardiac Sarcoidosis

    Omar Abialmouna1, Mohamad Kalot2, Mohamad Hamade3, Ronak Bahuva2, Ariba Hasmi2, Aamir Ahmed2, Zachary Brumberger2, Jordan Troy2, Ali Choaib4, Ronak Bharucha2, Ross Moyer2, Karin Provost2, Brian Page2 and Umesh Sharma2, 1University at Buffalo, North Tonawanda, NY, 2University at Buffalo, Buffalo, NY, 3University of Miami, Miami, FL, 4Lebanese American University, Beirut, Lebanon

    Background/Purpose: Autopsy reports for patients with sarcoidosis have suggested that up to 25% have cardiac involvement, mostly undiagnosed. Given the limited diagnostic accuracy of endomyocardial…
  • Abstract Number: 1578 • ACR Convergence 2022

    Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review and Meta-analysis

    Francis Lao1, Cal Robinson2, Megan Schlorff1, Joycelynn Ewusie3, KAREN BEATTIE1 and Michelle Batthish1, 1McMaster University, Hamilton, ON, Canada, 2The Hospital for Sick Children, Hamilton, ON, Canada, 3St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: Kawasaki Disease (KD) is a common childhood vasculitis. Coronary artery aneurysms (CAAs) develop in approximately 25% of untreated KD patients. However, there is limited…
  • Abstract Number: 1766 • ACR Convergence 2022

    COVID-19 Cutaneous and Systemic Manifestations Among Race: A Systematic Review and Meta-Analysis

    Angie El-Said1, Areeb Ahmad2, Massimo Valenti3, Neel K. Shah1, Susana Soto1 and Shazia Beg4, 1University of Central Florida College of Medicine, Orlando, FL, 2University of Central Florida, Orlando, FL, 3Sapienza University of Rome, School of Medicine, Rome, Italy, 4UCF, Orlando, FL

    Background/Purpose: Although various systemic and dermatologic manifestations associated with COVID-19 have been reported in the literature, investigations of how these manifestations vary by race remain…
  • Abstract Number: 1770 • ACR Convergence 2022

    Prevalence and Incidence of Depression in Patients with Rheumatoid Arthritis: A Systematic Review

    John E Oghene1, Griffin Reed2, Ian Saldanha3, Pooja Reddy4, Ahmed Elshazly5, Yuvaraj Singh6 and Deepan Dalal7, 1Hospital of the University of Pennsylvania, Philadelphia, PA, 2Rhode island hospital, Brown University Warren Alpert School of Medicine, Providence, RI, 3Brown University School of Public Health, Providence, RI, 4Rhode island hospital, Brown University Warren Alpert School of Medicine, Seekonk, MA, 5Westerly Hospital, Yale New Haven Health, Westerly, RI, 6Saint Vincent Hospital, Worcester, MA, 7Brown University School of Medicine, Providence, RI

    Background/Purpose: Depression is a common co-morbidity that has been shown to worsen symptoms such as pain, fatigue, decreased functional status, decreased disease remission, and response…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology